Trial intelligence / Profile preview

Evaluation of Bleeding Risk in Hemodialysis via PFA-100

NCT02792283Completed

Sponsor
CHU de Reims
Start
Jan 2016
Primary completion
Dec 2017
Countries
1
01

Overview

Single-arm trial, sponsored by CHU de Reims. Primary endpoint: PFA-100 quantification. Started Jan 2016; status: completed.

Beyond the preview

Go deeper on NCT02792283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02792283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call